EUVIMEDEUVIMED entdecken
Crossref

CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo

Hyung Ho Yoon, Sunghyeok Ye, Sunhwa Lim, Ara Jo, Hawon Lee, Felix Hong, Seung Eun Lee, Soo-Jin Oh, Na-Rae Kim, Kyoungmi Kim, Bum-Joon Kim, Hyunjin Kim und 4 weitere

The CRISPR Journal · 01.02.2022 · 5 (1) · 95-108

DOI: 10.1089/crispr.2021.0025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 22.02.2022. Verfasst von Hyung Ho Yoon und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Kyung Hee University, Seoul, Korea. Hauptthemen laut MEDLINE: Gene Editing, Parkinson Disease, alpha-Synuclein. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in specific genes, including synuclein alpha ( SNCA ) that encodes the α-synuclein protein, are known to be risk factors for sporadic Parkinson's disease (PD), as well as critical factors for familial PD. In particular, A53T-mutated SNCA (A53T-SNCA) is a well-studied familial pathologic mutation in PD. However, techniques for deletion of the mutated SNCA gene in vivo have not been developed. Here, we used the CRISPR-Cas9 system to delete A53T-SNCA in vitro as well as in vivo . Adeno-associated virus carrying SaCas9-KKH with a single-guide RNA targeting A53T-SNCA significantly reduced A53T-SNCA expression levels in vitro . Furthermore, we tested its therapeutic potential in vivo in a viral A53T-SNCA-overexpressing rat model of PD. Gene deletion of A53T-SNCA significantly rescued the overexpression of α-synuclein, reactive microgliosis, dopaminergic neurodegeneration, and parkinsonian motor symptoms. Our findings propose CRISPR-Cas9 system as a potential prevention strategy for A53T-SNCA-specific PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingParkinson Diseasealpha-SynucleinAnimalsCRISPR-Cas SystemsMutationRats

Substanzen

SNCA protein, humanalpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Kyung Hee University, Seoul, Korea.
  • RnD center, GeneCker, Seoul, Korea; Kyung Hee University, Seoul, Korea.
  • Convergence Research Center for Dementia, Korea Institute of Science and Technology, Seoul, Korea; Kyung Hee University, Seoul, Korea.
  • Brain Science Institute, Korea Institute of Science and Technology, Seoul, Korea; Kyung Hee University, Seoul, Korea.
  • Department of Neurosurgery, College of Medicine, Korea University, Seoul, Korea; Kyung Hee University, Seoul, Korea.
  • Virus Facility, Research Animal Resource Center, Korea Institute of Science and Technology, Seoul, Korea; Kyung Hee University, Seoul, Korea.

Zitieren

APA

Yoon, H. H., Ye, S., Lim, S., Jo, A., Lee, H., Hong, F., Lee, S. E., Oh, S. J., Kim, N. R., Kim, K., Kim, B. J., Kim, H., Lee, C. J., Nam, M. H., Hur, J. W., & Jeon, S. R. (2022). CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo. The CRISPR Journal, 5(1), 95-108. https://doi.org/10.1089/crispr.2021.0025

Vancouver

Yoon HH, Ye S, Lim S, Jo A, Lee H, Hong F, et al. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo. The CRISPR Journal. 2022;5(1):95-108. doi:10.1089/crispr.2021.0025

BibTeX
@article{Yoon2022,
  author = {Yoon, Hyung Ho and Ye, Sunghyeok and Lim, Sunhwa and Jo, Ara and Lee, Hawon and Hong, Felix and Lee, Seung Eun and Oh, Soo-Jin and Kim, Na-Rae and Kim, Kyoungmi and Kim, Bum-Joon and Kim, Hyunjin and Lee, C Justin and Nam, Min-Ho and Hur, Junseok W and Jeon, Sang Ryong},
  title = {CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo},
  journal = {The CRISPR Journal},
  year = {2022},
  volume = {5},
  number = {1},
  pages = {95--108},
  doi = {10.1089/crispr.2021.0025}
}
Kostenlos starten →